Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Drug Dev Ind Pharm ; 50(4): 285-296, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38486377

RESUMO

The overactive bladder is a condition characterized by a sudden urge to urinate, even with small volumes of urine present in the bladder. The current treatments available for this pathology consist on conservative approaches and the continuous administration of drugs, which when made by conventional methods has limitations related to the first pass metabolism, bioavailability, severe side effects, and low patient adherence to treatments, ultimately leading to low effectiveness. Within this context, the present work proposes the design, manufacture, and characterization of an intravesical implant for the treatment of overactive bladder pathology, using EVA copolymer as a matrix and oxybutynin as a drug. The fabrication of devices through two manufacturing techniques (extrusion and additive manufacturing by fused filament fabrication, FFF) and the evaluation of the implants through characterization tests was proposed. The usability and functionality were evaluated through simulated insertion of the device/prototype in a bladder model through catheter insertion tests. The safety and effectiveness of the devices was investigated from mechanical testing as well as drug release assays. Drug release assays presented a burst release in the first 24 h, followed by a release of 1.8 and 2.8 mg/d, totalizing 32 d. Mechanical tests demonstrated an increase in the stiffness of the specimens due to the addition of the drug, showing a change in maximum stress and strain at break. The released dose was higher than that usually presented when considering the oral administration route, showing the optimization of the development of this implant has the potential to improve the quality of life of patients with overactive bladder.


Assuntos
Bexiga Urinária Hiperativa , Compostos de Vinila , Humanos , Bexiga Urinária Hiperativa/tratamento farmacológico , Preparações Farmacêuticas , Qualidade de Vida , Etilenos/uso terapêutico , Impressão Tridimensional
2.
Electron. j. biotechnol ; Electron. j. biotechnol;12(2): 8-9, Apr. 2009. ilus, tab
Artigo em Inglês | LILACS | ID: lil-551369

RESUMO

The aim of this review is to critically analyze the role of silver nitrate (AgNO3) in modulating plant growth and development. In recent years, basic studies on ethylene regulation opened new vistas for applied research in the area of micro-propagation, somatic embryogenesis, in vitro flowering, growth promotion, fruit ripening, and sex expression. Silver nitrate has proved to be a very potent inhibitor of ethylene action and is widely used in plant tissue culture. Few properties of silver nitrate such as easy availability, solubility in water, specificity and stability make it very useful for various applications in exploiting plant growth regulation and morphogenesis in vivo and in vitro. Silver ion mediated responses seem to be involved in polyamines, ethylene- and calcium- mediated pathways, and play a crucial role in regulating physiological process including morphogenesis. The molecular basis for regulation of morphogenesis under the influence of silver nitrate is completely lacking. This review compiles published reports of silver nitrate-mediated in vitro and in vivo studies and focuses on fundamental and applied aspects of plant growth modulation under the influence of silver nitrate.


Assuntos
Nitrato de Prata/administração & dosagem , Nitrato de Prata/agonistas , Plantas/crescimento & desenvolvimento , Plantas , Plantas/metabolismo , Etilenos/administração & dosagem , Etilenos/antagonistas & inibidores , Etilenos/uso terapêutico , Engenharia Genética , Morfogênese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA